
Keywords: ضد CD20; anti-CD20; autoimmune; biologics; blistering diseases; desmoglein; desmosomes; immunomodulators; immunosuppression; monoclonal antibodies; pemphigus vulgaris; rituximabADCC, antibody-dependent cell-mediated cytotoxicity; CDC, complement-dependent cytotoxi